On the upside
Anadys Pharmaceuticals (Nasdaq: ANDS) reported that a Phase 1b clinical trial of its ANA598 demonstrated potent antiviral activity in Hepatitis C patients.Although Shaw Group (NYSE: SGR) swung to a loss for the first quarter, the results topped analyst estimates.
Same store sales for GameStop (NYSE: GME) surged 10.2% from November 2 thru January 3 due to strong sales of new games.
On the downside
Ulta Salon, Cosmetics & Fragrance (Nasdaq: ULTA) blamed disappointing holiday sales for cutting its fourth quarter outlook and trimmed its full year guidance for the second time.Parametric Technology (Nasdaq: PMTC) cited lower license sales for offering first quarter profit outlook below expectations.
Ion Geophysical (NYSE: IO) warned that fourth quarter revenue will plunge 31% and full year revenue will fall short of expectations due to the slumping global economy.
In the broad market, declining issues outpaced advancers by a margin of 5 to 4 on the NYSE while advancers barely edged out decliners on Nasdaq. The Russell 2000 which tracks small cap stocks eased a fraction to 497.
